Viking Therapeutics (VKTX) Tops Q4 EPS by 4c
Get Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).
At December 31, 2017, Viking held cash, cash equivalents and investments totaling $20.6 million. In February 2018, Viking sold an aggregate of 12,650,000 shares of its common stock resulting in gross proceeds of $63.3 million before deducting underwriting discounts and commissions and other offering expenses. As of February 28, 2018, Viking had 50,898,802 shares of common stock outstanding.
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
- West Bancorporation (WTBA) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!